<DOC>
	<DOCNO>NCT02121158</DOCNO>
	<brief_summary>The overall aim trial study safety efficacy ICD implantation primary prevention strategy sudden cardiac death patient 70 year old . This study assess many compete factor involve ICD implantation include 1 ) impact mortality , especially context decline rate sudden death advanced age , 2 ) tolerability powerful therapeutic action device , 3 ) impact quality life .</brief_summary>
	<brief_title>Efficacy Safety Implantable Cardioverter-Defibrillator ( ICD ) Implantation Elderly</brief_title>
	<detailed_description>The overall aim trial study safety efficacy ICD implantation primary prevention strategy sudden cardiac death ( SCD ) patient 70 year old . In particular , study design determine comparative effectiveness ICD , addition optimal medical therapy ( OMT ) , reduce all-cause mortality , versus OMT alone ; OMT include standard intervention chronic heart failure patient , i.e . lifestyle modification , disease management , adoption healthy diet exercise practice , etcetera . One particularly important secondary objective ass treatment efficacy condition high versus low co-morbidity burden . Participants randomize ( 1:1 ratio ) ICD + OMT OMT alone , stratify participate site co-morbidity level ( Charlson score &lt; 3 versus 3+ ) . Acute treatment visit occur clinically indicate per local convention ; follow-up occur 1-4 month post-randomization ( participant ) , sooner 30 day - later 120 day post-implantation ( ICD arm ) ; regular follow-up occur 6 month interval post-randomization study close ( participant ) . All follow-up conduct centrally . Neither participant treating clinician mask treatment . Primary Objective : The primary objective study determine primary prevention strategy ICD implantation addition optimal medical therapy ( OMT ) effective reduce all-cause mortality compare OMT alone patient 70 year age old eligible ICD therapy accord current Centers Medicare &amp; Medicaid Services ( CMS ) criterion . Primary Hypothesis : The primary hypothesis study implantation ICD plus optimal medical therapy reduce all-cause mortality patient 70 year age old versus optimal medical therapy alone . Secondary Objectives : 1 . One secondary objective study ascertain whether age , co-morbidity burden , age burden together , determinant mortality outcomes OMT versus ICD + OMT group . 2 . An additional secondary objective study determine effect ICD implantation plus optimal medical therapy quality life among elderly patient compare optimal medical therapy .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Cardiomyopathies</mesh_term>
	<criteria>1 . 70 year age old 2 . Eligible ICD implementation accord CMS criterion primary prevention one follow condition : 1 . Documented prior MI measure leave ventricular ejection fraction ( LVEF ) &lt; =30 % ( include New York Heart Association [ NYHA ] class I , II , III ) 2 . Coronary artery disease document prior MI , measure leave ventricular ejection fraction &lt; =35 % , inducible , sustain ventricular tachycardia ( VT ) ventricular fibrillation ( VF ) electrophysiology ( EP ) study 3 . Ischemic dilate cardiomyopathy ( IDCM ) , document prior MI , NYHA class II III heart failure , measure LVEF &lt; =35 % 4 . Nonischemic dilate cardiomyopathy ( NIDCM ) &gt; 3 month , NYHA Class II III heart failure , measure LVEF &lt; =35 % 3 . Stable condition Optimal Medical Therapy 4 . Able willing provide inform consent participate study 1 . Enrolled planning enroll conflict trial 2 . Receiving biventricular ICD device 3 . New York Heart Association class IV heart failure 4 . Cardiogenic shock symptomatic hypotension stable baseline rhythm , 5 . Coronary artery bypass graft ( CABG ) percutaneous transluminal coronary angioplasty ( PTCA ) within past 3 month 6 . An MI within past 40 day 7 . Clinical symptom finding would make candidate coronary revascularization 8 . Irreversible brain damage preexist cerebral disease 9 . Any disease cardiac disease ( e.g . cancer , uremia , liver failure ) , associate likelihood survival less 1 year 10 . Circumstance would prevent completion trial followup activity , include medical condition</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>CSP 592</keyword>
	<keyword>ICD</keyword>
	<keyword>cardiovascular</keyword>
	<keyword>heart</keyword>
	<keyword>age</keyword>
	<keyword>chronic disease</keyword>
	<keyword>multi-site trial</keyword>
	<keyword>phase 3</keyword>
	<keyword>investigational device</keyword>
	<keyword>cardiomyopathy</keyword>
	<keyword>coronary artery disease</keyword>
	<keyword>congestive heart failure</keyword>
	<keyword>myocardial infarction</keyword>
	<keyword>I-70</keyword>
	<keyword>I70</keyword>
	<keyword>elderly</keyword>
	<keyword>defibrillator</keyword>
</DOC>